Membrane Properties: Neurotransmitters/neuromodulators
This inventory gives a complete overview of the main types of neurotransmitters and neuromodulators that have been identified. Supporting data to fill the tables is still being added. The list of neurotransmitters and neuromodulators for NeuronDB is a subset of this inventory. The inventory is based on Alexander & Peters (2000)
List of receptors (alphabetical)
Neurotransmitter/Neuromodulator | Receptors |
---|---|
5-Hydroxytryptamine (5-HT, serotonin) | 5-Hydroxytryptamine receptors |
serotonin (5-HT) | 5-Hydroxytryptamine receptors |
Acetylcholine | Acetylcholine receptors, muscarinic |
Acetylcholine | Acetylcholine receptors, nicotinic |
Adenosine | Adenosine receptors |
adrenaline | Adrenoceptors , alpha |
epinephrine | Adrenoceptors , alpha |
epinephrine | Adrenoceptors ,beta |
adrenaline | Adrenoceptors, beta |
Angiotensin II (Ang II) | Angiotensin receptors |
Angiotensin III (Ang III) | Angiotensin receptors |
Atrial natriuretic peptide (ANP) | Atrial natriuretic peptide receptors |
Brain natriuretic peptide (BNP) | Atrial natriuretic peptide receptors |
type C-natriuretic peptide (CNP) | Atrial natriuretic peptide receptors |
Gastrin-releasing peptide (GRP) | Bombesin receptors |
neuromedin B (NMB) | Bombesin receptors |
Bradykinin (BK) | Bradykinin receptors |
Calcitonin, | Calcitonin, amylin, CGRP and adrenomedullin receptors |
amylin | Calcitonin, amylin, CGRP and adrenomedullin receptors |
CGRP | Calcitonin, amylin, CGRP and adrenomedullin receptors |
adrenomedullin | Calcitonin, amylin, CGRP and adrenomedullin receptors |
Cannabinoids | Cannabinoid receptors |
CC Chemokines | Chemokine receptors, CC |
CXC Chemokines | Chemokine receptors, CC |
CX3C Chemokines | Chemokine receptors, CC |
CC Chemokines | Chemokine receptors, CX3C |
CXC Chemokines | Chemokine receptors, CX3C |
CX3C Chemokines | Chemokine receptors, CX3C |
C3a | Chemotactic peptide receptors |
C5a | Chemotactic peptide receptors |
Cholecystokinin-4 (CCK-4) | Cholecystokinin and gastrin receptors |
Cholecystokinin-8 (CCK-8) | Cholecystokinin and gastrin receptors |
Cholecystokinin-33 (CCK-33) | Cholecystokinin and gastrin receptors |
gastrin | Cholecystokinin and gastrin receptors |
Carbon monoxide (CO) | CO receptors ? |
Corticotropin-releasing factor (CRF) aka CRH | Corticotropin-releasing factor rceptors |
Corticotropin-releasing hormone(CRH) aka CRF | Corticotropin-releasing factor rceptors |
urocortin | Corticotropin-releasing factor rceptors |
Dopamine | Dopamine receptors |
Endothelin-1 (ET-1) | Endothelin receptors |
Endothelin-2 (ET-2) | Endothelin receptors |
Endothelin-3 (ET-3) | Endothelin receptors |
GABA | GABA receptors |
Galanin and galanin-like peptides (GALP) | Galanin receptors |
Glutamate | Glutamate receptors, Ionotropic |
Glutamate | Glutamate receptors, Metabotropic |
L-aspartate | Glutamate receptors, Metabotropic |
alanine, beta | glycine receptors |
taurine | glycine receptors |
Glycine | Glycine receptors |
Glycoprotein hormones: FSH, LH,CG,TSH | Glycoprotein hormone receptors |
follitropin, follicle-stimulating hormone, FSH | Glycoprotein hormone receptors |
Lutriopin, Luteinizing hormone, LH | Glycoprotein hormone receptors |
choriogonadotropin, chorionic gonadotropin, CG | Glycoprotein hormone receptors |
thyrotropin, thyroid-stimulation hormone, TSH | Glycoprotein hormone receptors |
Histamine | Histamine receptors |
Ins(1,4,5)P3(IP3) | Ins(1,4,5)P3(IP3) receptors |
cytosolic Ca | Ins(1,4,5)P3(IP3) receptors |
cytosolic ATP. | Ins(1,4,5)P3(IP3) receptors |
Leukotriene (LT) B4 | Leukotriene receptors |
Leukotriene (LT) LTC4 | Leukotriene receptors |
Leukotriene (LT) LTD4 | Leukotriene receptors |
Leukotriene (LT) LTE4 | Leukotriene receptors |
Sphingosine-1-phosphate(S1P) | Lysophospholipid receptors |
sphingosylphosphorylcholine(SPC) | Lysophospholipid receptors |
lysophosphatidic acid (LPA) | Lysophospholipid receptors |
Melanocortin (MSH) | Melanocortin receptors |
adrenocorticotrophin (ACTH) | Melanocortin receptors |
Melatonin (MLT) | Melatonin receptors |
N-acetylserotonin | Melatonin receptors |
Neuropeptide Y (NPY) | Neuropeptide Y receptors |
pancreatic polypeptide (PP) | Neuropeptide Y receptors |
peptide YY (PYY) | Neuropeptide Y receptors |
Neurotensin | Neurotensin receptors |
Neurotrophin (NT) | Neurotrophin receptors |
Nerve growth factor (NGF) | Neurotrophin receptors |
Brain-derived neurotrophic factor (BDNF) | Neurotrophin receptors |
Nitric oxide (NO) | NO receptors (sGC, soluble guanylate cyclase?) |
enkephalin (leu) | Opioid and opioid-like receptors |
enkephalin (met) | Opioid and opioid-like receptors |
b-endorphin | Opioid and opioid-like receptors |
a-neo-dynorphin | Opioid and opioid-like receptors |
dynorphin A (dyn A) | Opioid and opioid-like receptors |
dynorphin B (dyn B) | Opioid and opioid-like receptors |
2-MeSATP | P2X receptors (transmitter-gated channels) |
ATP | P2Y receptors (G-protein-coupled) |
UTP | P2Y receptors (G-protein-coupled) |
ADP | P2Y receptors (G-protein-coupled) |
UDP | P2Y receptors (G-protein-coupled) |
Ap3A | P2Y receptors (G-protein-coupled) |
Ap4A | P2Y receptors (G-protein-coupled) |
Ap5A | P2Y receptors (G-protein-coupled) |
Peroxisome proliferator : e.g. hypolipidaemic drugs, fatty acids . | Peroxisome proliferator activated receptors |
hypolipidaemic drugs | Peroxisome proliferator activated receptors |
fatty acids . | Peroxisome proliferator activated receptors |
Prostaglandin (PG) | Prostanoid receptors |
Prostaglandin (PG) D | Prostanoid receptors |
Prostaglandin (PG) E | Prostanoid receptors |
Prostaglandin (PG) F | Prostanoid receptors |
Prostaglandin (PG) H | Prostanoid receptors |
Prostacyclin | Prostanoid receptors |
thromboxane A2 | Prostanoid receptors |
thrombin | Protease-activated receptors |
Cytosolic Ca | Ryanodine receptors |
cytosolic ATP | Ryanodine receptors |
luminal Ca | Ryanodine receptors |
CaM Kinase | Ryanodine receptors |
PKA | Ryanodine receptors |
Ryanodine: pharmacological activators | Ryanodine receptors |
Caffeine: pharmacological activators | Ryanodine receptors |
Suramin: pharmacological activators | Ryanodine receptors |
Somatostatin-14 (SRIF-14) | Somatostatin receptors |
Somatostatin-28 ( SRIF-28) | Somatostatin receptors |
cortistatin (CST-14) | Somatostatin receptors |
Steroid hormones: 5a-Dihydrotestosterone (DHT) aldosterone cortisol cortisosterone testosterone | Steroid hormone receptors |
5a-Dihydrotestosterone (DHT) | Steroid hormone receptors |
aldosterone | Steroid hormone receptors |
cortisol | Steroid hormone receptors |
cortisosterone | Steroid hormone receptors |
testosterone | Steroid hormone receptors |
Substance P (SP) | Tachykinin receptors |
neurokinin A (NKA) | Tachykinin receptors |
neurokinin B | Tachykinin receptors |
neuropeptide K | Tachykinin receptors |
neuropeptide g | Tachykinin receptors |
Thyrotropin-releasing hormone (TRH) | Thyrotropin-releasing hormone receptors |
Vasoactive intentinal peptide (VIP) | Vasoactive intentinal peptide and pituitary adenylate cyclase activating peptide receptors |
pituitary adenylate cyclase activating polypeptide (PACAP) | Vasoactive intentinal peptide and pituitary adenylate cyclase activating peptide receptors |
peptide histidine isoleucineamide (PHI), | Vasoactive intentinal peptide and pituitary adenylate cyclase activating peptide receptors |
peptide histidine methionineamide (PHM), | Vasoactive intentinal peptide and pituitary adenylate cyclase activating peptide receptors |
peptide histidine valine | Vasoactive intentinal peptide and pituitary adenylate cyclase activating peptide receptors |
growth hormone-releasing factor (GRF) | Vasoactive intentinal peptide and pituitary adenylate cyclase activating peptide receptors |
Arginine Vasopressin (VP) | Vasopressin and oxytocin receptors |
oxytocin (OT) | Vasopressin and oxytocin receptors |
Reference:
Alexander, S.P.H. and Peters, J.A. (2000) Receptor and Ion Channel Nomenclature Supplement. Trends in Pharmacological Sciences